K. Hatano

发表

Structural requirements for the stability of novel cephalosporins to AmpC beta-lactamase based on 3D-structure.

T. Takagi, K. Itoh, K. Murano, 2008, Bioorganic & medicinal chemistry.

Gender-based differences in bleomycin-induced pulmonary fibrosis.

S. Phan, M. Gharaee-Kermani, K. Hatano, 2005, The American journal of pathology.

In vivo antibacterial activity of FK041, a new orally active cephalosporin.

Y. Watanabe, S. Matsumoto, Y. Wakai, 1999, The Journal of antibiotics.

In vitro antibacterial activity of FK041, a new orally active cephalosporin.

Y. Matsumoto, Y. Watanabe, H. Takasugi, 1999, The Journal of antibiotics.

Lung interleukin-4 gene expression in a murine model of bleomycin-induced pulmonary fibrosis.

S. Phan, M. Gharaee-Kermani, K. Hatano, 2001, Cytokine.

Efficacy of FK463, a New Lipopeptide Antifungal Agent, in Mouse Models of Pulmonary Aspergillosis

F. Ikeda, T. Goto, S. Matsumoto, 2000, Antimicrobial Agents and Chemotherapy.

A NOVEL PARENTERAL BROAD-SPECTRUM CEPHALOSPORIN , AGAINST METHICILLIN-RESISTANT STAPHYLOCOCCI

Mine, Y. Matsumoto, K. Hatano, 2006 .

Excellent activity of FK037, a novel parenteral broad-spectrum cephalosporin, against methicillin-resistant staphylococci.

Y. Matsumoto, T. Kamimura, Y. Mine, 1993, The Journal of antibiotics.

In vitro antibacterial activity of FK037, a novel parenteral broad-spectrum cephalosporin.

Y. Matsumoto, T. Kamimura, Y. Mine, 1993, The Journal of antibiotics.

In Vitro Antimicrobial Activity of Telavancin against Methicillin-resistant Staphylococcus aureus Clinical Isolates from Japan (2006)

K. Yamaguchi, I. Kobayashi, K. Hatano, 2007, The Journal of Antibiotics.

Electron microscopic findings for micafungin-treated experimental pulmonary aspergillosis in mice.

F. Ikeda, K. Shibuya, K. Hatano, 2005, Medical mycology.

Morphological alterations of Staphylococcus aureus and Streptococcus pyogenes exposed to cefdinir, a new oral broad-spectrum cephalosporin.

T. Nishino, K. Hatano, 1994, Chemotherapy.

Tacrolimus Has Antifungal Activities against Malassezia furfur Isolated from Healthy Adults and Patients with Atopic Dermatitis

H. Nakagawa, Y. Yokota, F. Ikeda, 1996 .

Induction of telomerase activity in fibroblasts from bleomycin-injured lungs.

S. Phan, Tianju Liu, M. Gharaee-Kermani, 2000, American journal of respiratory cell and molecular biology.

Synthesis and SAR of novel parenteral anti-pseudomonal cephalosporins: discovery of FR264205.

K. Itoh, K. Murano, T. Yamanaka, 2008, Bioorganic & medicinal chemistry letters.

Novel Carbapenem Antibiotics for Parenteral and Oral Applications: In Vitro and In Vivo Activities of 2-Aryl Carbapenems and Their Pharmacokinetics in Laboratory Animals

Y. Ueda, S. Terashita, K. Takemoto, 2012, Antimicrobial Agents and Chemotherapy.

Killing Activity of Micafungin against Aspergillus fumigatus Hyphae Assessed by Specific Fluorescent Staining for Cell Viability

F. Ikeda, S. Matsumoto, K. Hatano, 2003, Antimicrobial Agents and Chemotherapy.

Antifungal mechanism of FK463 against Candida albicans and Aspergillus fumigatus.

F. Ikeda, K. Hatano, T. Nakai, 2002, The Journal of antibiotics.

Pharmacokinetics of FK482, a new orally active cephalosporin, in animals.

Y. Mine, S. Kuwahara, K. Hatano, 1988, The Journal of antibiotics.

Evidence for the involvement of GABAA receptor blockade in convulsions induced by cephalosporins

T. Mashimo, N. Matsuoka, F. Ikeda, 2003, Neuropharmacology.

In Vitro and In Vivo Activities of a New Cephalosporin, FR264205, against Pseudomonas aeruginosa

F. Ikeda, Y. Wakai, K. Hatano, 2006, Antimicrobial Agents and Chemotherapy.

Role of motility in the endogenousPseudomonas aeruginosa sepsis after burn

Tetsuya Matsumoto, K. Tateda, N. Furuya, 1996, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

In vitro and in vivo antibacterial activities of FK037, a new parenteral cephalosporin.

T. Nishino, K. Hatano, Y. Nishihara, 1994, Chemotherapy.

Bacterial translocation of intestinalPseudomonas aeruginosa in post-burn infection of mice

Tetsuya Matsumoto, K. Tateda, N. Furuya, 1996, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

Stability of FR264205 against AmpC β-lactamase of Pseudomonas aeruginosa

K. Tateda, Y. Ishii, K. Yamaguchi, 2007 .

Stability of FR264205 against AmpC beta-lactamase of Pseudomonas aeruginosa.

K. Tateda, Y. Ishii, K. Yamaguchi, 2007, International journal of antimicrobial agents.

Characterization of a Multigene-Encoded Sodium/Hydrogen Antiporter (Sha) from Pseudomonas aeruginosa: Its Involvement in Pathogenesis

K. Haga, T. Kudo, S. Kosono, 2005, Journal of bacteriology.

Animal pharmacokinetics of FK037, a novel parenteral broad-spectrum cephalosporin.

T. Kamimura, Y. Mine, Y. Higashi, 1993, The Journal of antibiotics.

In Vitro and In Vivo Activities of a New Cephalosporin, FR264205, against Pseudomonas aeruginosa (cid:1)

F. Ikeda, Y. Wakai, K. Hatano, 2007 .

In Vitro Antibacterial Activity of a New Cephalosporin, FR295389, against IMP-type Metallo-β-lactamase-producers

F. Ikeda, K. Hatano, Shinobu Takeda, 2008, The Journal of Antibiotics.

In vitro Antibacterial Activity of a New Cephalosporin, FR295389, Against IMP-Type Metallo-β-lactamase Producers.

F. Ikeda, K. Hatano, Shinobu Takeda, 2008 .

Overproduction of a Metallo-β-Lactamase by a Strong Promoter Causes High-Level Imipenem Resistance in a Clinical Isolate of Pseudomonas aeruginosa

F. Ikeda, K. Hatano, Shinobu Takeda, 2008, Chemotherapy.

Evidence for the involvement of GABAA receptor blockade in convulsions induced by cephalosporins

T. Mashimo, N. Matsuoka, F. Ikeda, 2003, Neuropharmacology.